Difference between revisions of "Team:Peking/Demonstrate"

Line 278: Line 278:
 
                                 font-weight:300;
 
                                 font-weight:300;
 
                             }
 
                             }
 +
                        </style>
 
                          
 
                          
 
                          
 
                          
Line 307: Line 308:
 
                                 <p>[2] Sau-Ching, W. et al. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction. Proteins 77, 404-412 (2009).</p>
 
                                 <p>[2] Sau-Ching, W. et al. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction. Proteins 77, 404-412 (2009).</p>
 
                             </div>
 
                             </div>
 +
                           
 
                              
 
                              
 
                              
 
                              
 
                         </div><!--9 columns end-->
 
                         </div><!--9 columns end-->
 
                          
 
                          
−
                          
+
                         </div>
 
                          
 
                          
 
                          
 
                          

Revision as of 09:53, 15 October 2016

Recovery

Recovery.

What we have done in the project

Constructed a multifunctional protein sequences of interest via molecular biological methods, and introduced the constructed plasmids into the engineered bacteria for protein expression.

(Learn more)

Design


References:

[1] Christopher, D. et al. Streptavidin–biotin technology: improvements and innovations in chemical and biological applications. Appl Microbiol Biotechnol 97, 9343–9353 (2013).

[2] Sau-Ching, W. et al. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction. Proteins 77, 404-412 (2009).